Lactusan, 100 g

Lactulose is a non-digestible beta-glycoside carbohydrate. Due to the lack of human enzymes it is not hydrolyzed (not broken down) in the upper sections of the gastrointestinal tract.

Lactulose enters the colon unchanged, where it is broken down by the colon flora (bifido- and lactobacteria) to form low-molecular organic acids, which leads to a lower pH of the intestinal contents.

Under the influence of Lactusan the absorption of ammonia by large intestine and its elimination from the body increases, acidophilic bacteria growth is stimulated (including

Clinical effect comes within 2-3 days after the start of administration.

Indications

Lactusan is prescribed for:

when correcting the effects of antibiotic therapy;
for intestinal dysbiosis in adults and children of varying severity;
for liver diseases of various etiologies;
for chronic constipation in the elderly, children, pregnant women, and also in patients who have been on bed rest for a long time;
for colitis and other diseases of the gastrointestinal tract;
for salmonellosis and to protect against intestinal infections;
with renal failure;
for toxicosis of pregnant women with functional digestive disorders;
for allergic reactions;
to activate the intestinal immune system.

Pharmacological effect

Lactulose is an indigestible beta-glycosidic carbohydrate. Due to the lack of appropriate enzymes in humans, it is not hydrolyzed (not broken down) in the upper sections of the gastrointestinal tract.

Lactulose enters the colon unchanged, where it is broken down under the influence of colon flora (bifidobacteria and lactobacilli) to form low molecular weight organic acids, which leads to a decrease in the pH of the intestinal contents.

Under the influence of Lactusan, the absorption of ammonia by the colon and its removal from the body increases, the growth of acidophilic bacteria (including lactobacilli) is stimulated, the proliferation of proteolytic bacteria is suppressed and the formation of nitrogen-containing toxic substances, released by the proteolytic flora and playing an important role in the pathogenesis of hepatic encephalopathy, is reduced.

The clinical effect occurs within 2-3 days from the start of administration

Special instructions

If signs of diarrhea appear, the dose of Lactusan should be reduced by 2 times.

Composition

Active ingredient:

lactulose

Pregnancy

Maybe.

Contraindications

galactosemia;
lactase deficiency;
individual intolerance;

Side Effects

In the first days of taking Lactusan, flatulence may occur, which goes away within 3 days.

Sometimes a laxative effect is observed.

Interaction

Neomycin, antibiotics, as well as magnesium, aluminum and calcium-containing antacids reduce the effectiveness of lactulose. With the simultaneous use of laxatives, severe diarrhea may develop.

Overdose

In case of overdose, nausea, abdominal pain and diarrhea are possible, which requires dose adjustment of Lactusan.

If high doses are used for a long time in the treatment of hepatic encephalopathy, the patient may develop electrolyte imbalance due to diarrhea.

Short product description

Dietary supplement Not a medicine.
Before use, it is recommended to consult a doctor (specialist).

Storage conditions

The drug should be stored in a place protected from light and out of reach of children at a temperature not exceeding 20°C.

Shelf life

2 years.

Manufacturer

INAT-Pharma, Russia